Hepatology highlights
Nahum Méndez-Sánchez
,
Corresponding author
* Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico
Read
577
Timeswas read the article
242
Total PDF
335
Total HTML
Share statistics
array:23 [ "pii" => "S166526811930972X" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)30972-X" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "70728" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2014" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2014;13:716-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 56 "formatos" => array:3 [ "EPUB" => 13 "HTML" => 18 "PDF" => 25 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119309731" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)30973-1" "estado" => "S300" "fechaPublicacion" => "2014-11-01" "aid" => "70729" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "edi" "cita" => "Ann Hepatol. 2014;13:719-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 99 "formatos" => array:3 [ "EPUB" => 9 "HTML" => 46 "PDF" => 44 ] ] "en" => array:8 [ "idiomaDefecto" => true "titulo" => "MELD exception for liver transplantation in portopulmonary hypertension: current implementation and future considerations" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "719" "paginaFinal" => "721" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mateo Porres-Aguilar, Sonja D. Bartolome, Andres Duarte-Rojo" "autores" => array:3 [ 0 => array:3 [ "preGrado" => "M.D., FACP" "nombre" => "Mateo" "apellidos" => "Porres-Aguilar" ] 1 => array:2 [ "nombre" => "Sonja D." "apellidos" => "Bartolome" ] 2 => array:2 [ "nombre" => "Andres" "apellidos" => "Duarte-Rojo" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119309731?idApp=UINPBA00004N" "url" => "/16652681/0000001300000006/v1_201906150917/S1665268119309731/v1_201906150917/en/main.assets" ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Hepatology highlights" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "716" "paginaFinal" => "718" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Nahum Méndez-Sánchez" "autores" => array:1 [ 0 => array:5 [ "preGrado" => "MD, MSc, PhD, FAASLD, FACG, AGAF" "nombre" => "Nahum" "apellidos" => "Méndez-Sánchez" "email" => array:1 [ 0 => "nmendez@medicasur.org.mx" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "*" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:1 [ 0 => array:3 [ "entidad" => "Liver Research Unit, Medica Sur Clinic & Foundation. Mexico City, Mexico" "etiqueta" => "*" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "*" "correspondencia" => "Correspondence and reprint request:" ] ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="s0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0005">Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico</span><p id="p0005" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">López-Colombo, <span class="elsevierStyleItalic">et al.</span></span>Hepatitis C virus (HCV) transmission is mainly due to parenteral exposure. However, in absence of such risk factor, there are reports of intrafamilial spread of HCV and observational studies suggest an increased risk for households of infected subjects. This risk factor has been explored in the last two decades in different geographical areas around the world. However, there are contradictory results. Firstly, Ndong-Atome, <span class="elsevierStyleItalic">et al.</span><a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a>found in a cross-sectional study was conducted in Dienga, in Gabon, involving 195 household members of 14 index cases of HCV infection. The investigators found an overall prevalence of antibody to HCV among household members of infected cases of 6.7%, with a significantly higher prevalence among sexual partners (35.7%) than non-sexual partners (7%). Furthermore, the HCV strains infecting different household contacts of index cases were concordant in only 40%, each of who was a sexual partner. This, and the discordance in HCV genotypes infecting the household members, indicate a limited role for intrafamilial transmission of HCV in this population. In another study Honda, <span class="elsevierStyleItalic">et al</span>.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a> evaluated the risk of hepatitis C virus transmission through household contact with chronic carriers using nucleotide sequence analysis. HCV patients (76 patients) were divided into two groups: familial transmission of HCV was studied in group A (53 patients); group B (23 patients) served as nonfamilial controls for group A. Of 88 family members of group A patients, 18 (20%) had elevated serum ALT levels, 20 (23%) had antibodies against hepatitis C virus and 16 (18%) had hepatitis C virus RNA in serum. Nucleotide sequences of the region of the hepatitis C virus genome spanning the core and envelope genes were compared among the three groups. In group B, the average nucleotide sequence homology was 91.0% ± 2.29% (a pairwise comparison was made for each of the patients; n = 253). Isolates from two family members were significantly more homologous to isolates from corresponding patients in group A than to isolates from group B patients. Of the two isolates from family members, one was from a child whose mother was a patient (97.7% homology) and one was from a spouse (98.1% homology). These results strongly suggest familial transmission of the same HCV strain.</p><p id="p0010" class="elsevierStylePara elsevierViewall">In this issue <span class="elsevierStyleBold">López-Colombo, <span class="elsevierStyleItalic">et al.</span></span>determined the prevalence of HCV infection in patients and family members attending two primary care clinics. The investigators studied 10,214 subjects. They found 120 (1.17%) anti-HCV positive. Of the positive subjects, the HCV RNA was determined in 114 subjects and 36 were positive (31%). The more frequent risk factors were having a family history of cirrhosis (33.1%) and having a blood transfusion prior to 1995 (29%). The HCV genotypes found were 1a (29%), 1b (48.5%), 2/2b (12.8%), and 3a (6.5%). Also, the researches found an overall prevalence of antibody to HCV among household members of infected cases of 6.7%, with a significantly higher prevalence among sexual partners (35.7%) than non-sexual partners (7%).</p><p id="p0015" class="elsevierStylePara elsevierViewall">This is one of the first studies carried out in Mexico on HCV infection in patients and family members. The sample size of the study as well as the design are good. However, the present study was carried out in one state in an urban area in two Clinics. It would be interesting to know the characteristics of both clinics as well as the medical attention provided and more information on the social and demographic characteristics of the population studied.</p></span><span id="s0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="st0010">The role of <span class="elsevierStyleItalic">Interleukin 28B</span> gene polymorphism in Turkish patients with hepatocellular carcinoma</span><p id="p0020" class="elsevierStylePara elsevierViewall"><span class="elsevierStyleBold">Akkiz, <span class="elsevierStyleItalic">et al.</span></span>It has been reported that genetic polymorphisms near the <span class="elsevierStyleItalic">interleukin-28B</span> (IL28B) gene might strongly associated with spontaneous and treatment-induced clearance of HCV.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Also IL28B has been associated with a poor treatment response rs12979860 T allele in patients with HCV infection and the liver fibrosis progression rate and the development of HCC.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="p0025" class="elsevierStylePara elsevierViewall">In this issue <span class="elsevierStyleBold">Akkiz, <span class="elsevierStyleItalic">et al.</span></span>investigated whether the rs12979860 polymorphism of IL28B gene affects the risk of HCC. Those investigators carried out a case-control study of 187 confirmed HCC patients and 208 healthy subjects (cancer and viral infection negative) and they found that the allele and genotype analysis showed no significant differences between the risk of HCC and IL28B gene rs12979860 polymorphism (OR = 1.10; 95% 0.59-2.08 P = 0.76 for genotype). However, in the HBV-related HCC subgroup, the TT genotype increased a 1.46-fold the risk of developing HCC, but not statistically significant (OR = 1.46; 95% 0.71-2.97 P = 0.30). The authors concluded that there is not significant association between IL28B rs12979860 genotypes with the risk of developing HCC in Turkish patients.</p><p id="p0030" class="elsevierStylePara elsevierViewall">Two important criticisms on this study are the sample size and the main clinical characteristics of the patients are missing. In fact, the sample size is not good enough to find some differences and interestingly the HCV genotypes were not included. However, it added a little of information on this hot topic that but need to confirm in future studies in different populations.</p><p id="p0035" class="elsevierStylePara elsevierViewall">One study from Italy by Fabris, <span class="elsevierStyleItalic">et al</span>.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> those investigators studied 412 patients with cirrhosis due to hepatitis C (n = 199), hepatitis B (n = 75), alcohol (n = 110), and other causes (n = 28), of whom 256 underwent liver transplantation (OLT). HCC was demonstrated in the native liver of 85 OLT patients, 52 with viral cirrhosis, and 33 with non-viral cirrhosis respectively. A group of 292 patients (235 HCV and 57 HBV positive) with mild chronic hepatitis and 344 healthy subjects served as controls. The investigators found a significant difference (p = 0.0005) was observed in IL-28B rs12979860 genotype frequencies between patients with viral cirrhosis (C/C = 99, C/T = 137, T/T = 38) and those with non-viral cirrhosis (C/C = 72, C/T = 58, T/T = 8). Patients with HCV related cirrhosis carried more frequently the T/T genotype in comparison to mild hepatitis C or HBV-related cirrhosis.</p><p id="p0040" class="elsevierStylePara elsevierViewall">In more recent study Bochud, <span class="elsevierStyleItalic">et al</span>.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> analyzed the association of IL28B polymorphisms with histological and follow-up features in 2335 chronically HCV-infected Caucasian patients. Assessable phenotypes before any antiviral treatment included necroinflammatory activity (n = 1,098), fibrosis (n = 1,527), fibrosis progression rate (n = 1,312), and HCC development (n = 1,915). The rare G allele at IL28B marker rs8099917 previously shown to be at risk of treatment failure was associated with lower activity (P = 0.04), lower fibrosis (P = 0.02) with a trend toward lower fibrosis progression rate (P = 0.06). When stratified according to HCV genotype, most significant associations were observed in patients infected with non-1 genotypes (P = 0.003 for activity, P = 0.001 for fibrosis, and P = 0.02 for fibrosis progression rate), where the odds ratio of having necroinflammation or rapid fibrosis progression for patients with IL28B genotypes TG or GG <span class="elsevierStyleItalic">vs.</span> TT were 0.48 (95% confidence intervals 0.30-0.78) and 0.56 (0.35-0.92), respectively. IL28B polymorphisms were not predictive of the development of HCC. Based on their results the investigators concluded that there is not association between IL28B polymorphisms and the occurrence of HCC among chronically HCV-infected patients, but the number of patients with HCC was likely insufficient to detect a significant effect, especially as the majority of patients with HCC were infected with HCV genotype 1 independent investigations are required to clarify the possible role of IL28B gene rs12979860 polymorphism on the risk of developing HCC in a larger series and also in patients of different ethnic origins.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:3 [ 0 => array:2 [ "identificador" => "s0005" "titulo" => "Hepatitis C virus infection in patients and family members attending two primary care clinics in Puebla, Mexico" ] 1 => array:2 [ "identificador" => "s0010" "titulo" => "The role of Interleukin 28B gene polymorphism in Turkish patients with hepatocellular carcinoma" ] 2 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bs0010" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Absence of intrafamilial transmission of hepatitis C virus and low risk for sexual transmission in rural central Africa indicate a cohort effect" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "Ndong-Atome G.R." 1 => "Njouom R." 2 => "Padilla C." 3 => "Bisvigou U." 4 => "Makuwa M." 5 => "Kazanji M." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jcv.2009.04.017" "Revista" => array:6 [ "tituloSerie" => "J Clin Virol" "fecha" => "2009" "volumen" => "45" "paginaInicial" => "349" "paginaFinal" => "353" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19473878" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "Honda M." 1 => "Kaneko S." 2 => "Unoura M." 3 => "Kobayashi K." 4 => "Murakami S." ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "1993" "volumen" => "17" "paginaInicial" => "971" "paginaFinal" => "976" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/8390397" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Ge D." 1 => "Fellay J." 2 => "Thompson A.J." 3 => "Simon J.S." 4 => "Shianna K.V." 5 => "Urban T.J." 6 => "Heinzen E.L." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature08309" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "2009" "volumen" => "461" "paginaInicial" => "399" "paginaFinal" => "401" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19684573" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Genetic variation in IL28B and spontaneous clearance of hepatitis C virus" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Thomas D.L." 1 => "Thio C.L." 2 => "Martin M.P." 3 => "Qi Y." 4 => "Ge D." 5 => "O’Huigin C." 6 => "Kidd J." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/nature08463" "Revista" => array:6 [ "tituloSerie" => "Nature" "fecha" => "2009" "volumen" => "461" "paginaInicial" => "798" "paginaFinal" => "801" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19759533" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "P. IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCC" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Fabris C." 1 => "Falleti E." 2 => "Cussigh A." 3 => "Bitetto D." 4 => "Fontanini E." 5 => "Bignulin S." 6 => "Cmet S." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhep.2010.07.019" "Revista" => array:6 [ "tituloSerie" => "J Hepatol" "fecha" => "2011" "volumen" => "54" "paginaInicial" => "716" "paginaFinal" => "722" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21146242" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:7 [ 0 => "Bochud P.Y." 1 => "Bibert S." 2 => "Kutalik Z." 3 => "Patin E." 4 => "Guergnon J." 5 => "Nalpas B." 6 => "Goossens N." ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.24678" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2012" "volumen" => "55" "paginaInicial" => "384" "paginaFinal" => "394" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22180014" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/0000001300000006/v1_201906150917/S166526811930972X/v1_201906150917/en/main.assets" "Apartado" => array:4 [ "identificador" => "77938" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Hepatology highlights" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/16652681/0000001300000006/v1_201906150917/S166526811930972X/v1_201906150917/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S166526811930972X?idApp=UINPBA00004N" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 1 | 0 | 1 |
| 2024 October | 4 | 1 | 5 |
| 2024 September | 8 | 1 | 9 |
| 2024 August | 7 | 3 | 10 |
| 2024 July | 8 | 3 | 11 |
| 2024 June | 6 | 3 | 9 |
| 2024 May | 5 | 0 | 5 |
| 2024 April | 10 | 3 | 13 |
| 2024 March | 8 | 4 | 12 |
| 2024 February | 2 | 6 | 8 |
| 2024 January | 7 | 2 | 9 |
| 2023 December | 1 | 3 | 4 |
| 2023 November | 4 | 1 | 5 |
| 2023 October | 8 | 2 | 10 |
| 2023 September | 5 | 3 | 8 |
| 2023 August | 2 | 3 | 5 |
| 2023 July | 2 | 3 | 5 |
| 2023 June | 2 | 3 | 5 |
| 2023 May | 6 | 1 | 7 |
| 2023 April | 4 | 0 | 4 |
| 2023 March | 4 | 1 | 5 |
| 2023 February | 7 | 0 | 7 |
| 2023 January | 7 | 1 | 8 |
| 2022 December | 4 | 1 | 5 |
| 2022 November | 7 | 8 | 15 |
| 2022 October | 5 | 11 | 16 |
| 2022 September | 7 | 4 | 11 |
| 2022 August | 4 | 5 | 9 |
| 2022 July | 7 | 5 | 12 |
| 2022 June | 7 | 5 | 12 |
| 2022 May | 6 | 4 | 10 |
| 2022 April | 8 | 6 | 14 |
| 2022 March | 6 | 4 | 10 |
| 2022 February | 9 | 4 | 13 |
| 2022 January | 16 | 6 | 22 |
| 2021 December | 6 | 7 | 13 |
| 2021 November | 8 | 4 | 12 |
| 2021 October | 6 | 8 | 14 |
| 2021 September | 6 | 7 | 13 |
| 2021 August | 3 | 5 | 8 |
| 2021 July | 6 | 8 | 14 |
| 2021 June | 5 | 8 | 13 |
| 2021 May | 7 | 10 | 17 |
| 2021 April | 14 | 9 | 23 |
| 2021 March | 7 | 2 | 9 |
| 2021 February | 3 | 10 | 13 |
| 2021 January | 3 | 3 | 6 |
| 2020 December | 4 | 5 | 9 |
| 2020 November | 5 | 7 | 12 |
| 2020 October | 5 | 4 | 9 |
| 2020 September | 4 | 3 | 7 |
| 2020 August | 4 | 1 | 5 |
| 2020 July | 4 | 1 | 5 |
| 2020 June | 3 | 0 | 3 |
| 2020 May | 2 | 2 | 4 |
| 2020 April | 4 | 1 | 5 |
| 2020 March | 3 | 1 | 4 |
| 2020 February | 2 | 1 | 3 |
| 2020 January | 3 | 2 | 5 |
| 2019 December | 4 | 5 | 9 |
| 2019 November | 3 | 0 | 3 |
| 2019 October | 2 | 1 | 3 |
| 2019 August | 3 | 3 | 6 |
| 2019 July | 1 | 7 | 8 |
| 2019 June | 1 | 7 | 8 |
Show all
